Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0063
0.00 (0.00%)
At close: Oct 20, 2026
Evofem Biosciences Market Cap
Evofem Biosciences has a market cap or net worth of $834.94 thousand as of October 20, 2026. It is the 49,702nd most valuable company in the world and the 6,784th biggest in the United States. Its market cap has decreased by 34.09% in one year.
Market Cap
834.94K
Enterprise Value
60.04M
Revenue
18.05M
Global Rank
Country Rank
#6,784 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since January 18, 2018, Evofem Biosciences's market cap has decreased from 215.21M to 834.94K, a decrease of -99.61%. That is a compound annual growth rate of -46.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 834.94K | -30.62% |
| Dec 31, 2025 | 1.20M | 7.24% |
| Dec 31, 2024 | 1.12M | -12.37% |
| Dec 29, 2023 | 1.28M | -83.76% |
| Dec 30, 2022 | 7.89M | -87.13% |
| Dec 31, 2021 | 61.26M | -68.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NKGen Biotech | 1.44M |
| Avenue Therapeutics | 1.42M |
| Protagenic Therapeutics | 1.36M |
| inTerra Resources | 1.30M |
| AXIM Biotechnologies | 1.23M |
| Aditxt | 1.20M |
| Halberd | 941.60K |
| Agentix | 801.34K |